Kathmandu, Nepal for the serological test. The test was done free of cost to the patients. It is a monoclonal based sandwich ELISA using monoclonal antibodies against excretory -secretory products (ES products) of living T. saginata cysticerci. This immunoassay can be used to monitor the evolution of circulating ES-products during the course of infection. It is used in diagnosis of the presence of living metacestodes of Taenia sp in human, porcine or bovine serum samples.
The serology for the circulation cysticercosis antigen (excretory-secretory product) was performed using sandwich ELISA technique. It has a maximum sensitivity of 85% in cases of multiple lesions and 65% in cases of single viable cyst or only enhancing lesions. The manufacturer indicated the possibility of cross reactivity with the serum from patients with other taeniids only.
stAtIstICAL ANALYsIs
All clinical and laboratory parameters were recorded in the proforma. The data were entered into Microsoft Excel 2003 spread sheet. Data were analyzed using SPSS (PC+) version 13.0. Test of significance for continuous variables was assessed by linear by linear association and for categorical test by Chisquare or Fisher's Exact Test. Test for association for risk factors for seropositivity for cysticercosis was done.
REsULts
Out of 90 cases, 51 were recruited from medical ward or emergency department and the rest (39) were recruited from medical or psychiatry OPD. The Male: Female ratio was 1.19:1. The age ranged from 16 to 78 years with a mean of 34.60 years ±16.96. The cases came from 13 different districts of Nepal and one case came from of India ( The cysticercosis antigen-ELISA test was done on all 90 serum samples and it was positive in 13 samples (15%). In one of the seropositive case, neuroimaging was not done. Seropositivity was assessed under various categorical variables and appropriate test of significance was applied (Table 3) . Significance was seen only those with abnormality in CT scan.
In the 13 (15%) of cases of neurocysticercosis defined by the serology, association of risk factors was analyzed by univariate analysis, ( Table 4) . None of them were seen to be significant although odds ratio (OR) was higher for age > 60years, family size > 5 members and consuming pork. The imaging studies and seropositivity was analyzed. Neuroimaging abnormalities suggestive of NCC were significantly associated with seropositivity. (Table 5 ). Association was looked for neuroimaging studies for single and multiple lesions separately for CT scan and MRI. (Table 6 ). Those with multiple lesions in neuroimaging (both for CT scan and MRI) were statistically significant with seropositivity. 
dIsCUssIoN:
The present study was carried out to study the seroprevalence of cysticercosis in adults presenting with seizure to B. P. Koirala Institute of Health Sciences, Dharan, Nepal. The serological test for the E-S product of cysticercosis using Ag-ELISA was performed in all 90 consecutive cases. The various sociodemographic and clinical profiles were studied and risk factors associated with seropositivity was evaluated.
In the cysticercosis, the diagnosis can be difficult. A consensus conference has proposed absolute, major, minor and epidemiological criteria for the diagnosis. 4 Diagnostic certainty is possible only with definitive demonstration of the parasite (absolute criteria). This task can be accomplished by histological observation of the parasite in excised tissue, by the fundoscopic visualization of the parasite in the eye (in anterior chamber, vitreous, or subretinal space) or by neuroimaging studies demonstrating cystic lesion containing the characteristic scolex. In most cases, diagnostic certainty is not possible. Instead a clinical diagnosis is made on the basis of a combination of clinical presentation, radiographic studies, serologic tests and exposure studies. 4 Various assays have been developed for the detection of T. solium antigen in serum or cerebrospinal fluid with variable result. 7 The present study was based on the monoclonal antibody based enzyme linked immunosorbent assay designed to detect the presence of excretory-secretory antigen from viable parasite. There are many studies done in various countries based on serology either for antigen or for antibody in community surveys or hospital setting with variable results. In a serological study undertaken in 3 rural Venezuelan communities (Conoabo, Sanare and Rio Tocuyo) using trapped ELISA to detect a secreted product of viable parasite showed the circulating parasite antigen of 9.1 % in Canoabo, 6.1 % in Sanare and 5.7% in Rio Tocuyo. 8 In a study from 3 rural localities in the West and Northwest provinces in Cameroon, T. solium antigen was detected in the sera of 1.2% of the patients. 9 In another study in Viet Nam done in 1999 had seropositivity of 5.7% of the community including all 5 persons with epilepsy for detecting circulating antigen. 10 The study which detected antibodies to T. solium cyst antigen showed higher prevalence of cysticercosis. For instance, seroprevalence to detect antibodies was reported 36.5% in Canoabo, 36.5% in Sanare and 4% in Rio Tocuyo in Venezuela. 8 Specific antibodies against the parasite were detected in 44.6% of the patients in Cameroon. 9 Antibodies against a specific form of antigen were detected in 15.2% of patients in the study done in Brazil. 11 Similarly the seroprevalence of human cysticercosis antibody was reported 8% in Peru, 10.8% in Mexico and ranged 10% to 17% in Guatemala. [12] [13] [14] The differences between Ag-ELISA and Ab-ELISA could be because Ag-ELISA detects only living cysts whereas Ab-ELISA detects dead cysts as well. However, antibody detection has 2 important limitations. Firstly it may indicate only exposure to infection and not necessarily the presence of established, viable infection and, secondly, antibody may persist long after the parasite has been eliminated through the immune mechanism and/or drug therapy. 15, 16 In the former case, the presence of antibodies to T. solium in a patient with neurological symptoms living in an endemic zone may result in false diagnosis of neurocysticercosis and delay the search for other pathological condition. In the latter, antiparasitic therapy may be unnecessarily indicated since the parasite may not be viable.
The studies done in hospital setting with those presented with seizure disorders also vary in their seropositivity rate. In a study in Brazil, 6% of the patients who attended an ambulating clinic in the district of Mulungu do Morro, had the circulating parasite product as tested by capture ELISA. 11 In a case control study for epilepsy in Burundi, Ag-ELISA revealed 38.3% positivity in epilepsy cases. 17 Study of 1038 randomly selected cases of epilepsy in Chandigarh showed the cysticercosis hemaagglutination test to a useful adjunct in the diagnosis of cysticercosis as an etiological factor. It was positive in 25.7% epileptic cases but in only 2% of healthy controls. 18 The higher rate of seropositivity compared to the present study is because they used hemaaglutination test to detect antibody against cysticercosis.
In a hospital based study done in Nepal during the period of 2002-2006 the occurrence of neurocysticercosis was 13.34% of epileptic admission episodes in 6 hospitals by using EITB. 19 The present study showed seroprevalence of 15% using antigen-ELISA in the adults presenting with seizures. The seropositivity rate is higher in our study even though we have used Ag-ELISA which is a better indicator of active infection than antibody based assay. Serological test using antibody may only indicate exposure to infection and antibody may persist long after the parasite has been eliminated. It appears that cysticercosis prevalence is much higher in Eastern Nepal. Further community based larger studies are needed to establish true seroprevalence. These variability's in seroprevalence rates are contributed by various factors depending on presence or absence of various risk factors in different communities including poverty, pork consumption, poor pig husbandry practices, hygiene standard and customs like consumption of raw pork in some communities. For example, it is almost non-existing in Japan and Singapore due to increasing economic prosperity and accompanying infrastructure; while in others such as the Islamic countries of the Middle East and West Asia, religious proscription of the consumption of pork had made a similar result. 20 The present study revealed that 11 of 26 (42.3%) of patients with seizure and active lesions in neuroimaging (CT or MRI) were seropositive. This is less than seropositivity specified in the literature which revealed 85% with multiple lesions and 65% in single lesion. This could be because almost a third (30%) patient had single ring enhancing lesion which may have low antigen detection rate. The seropositivity was relatively high (62.5%) in patients with multiple lesions.
No significant difference was observed between the prevalence in males and females in the present study. It showed no statistical significance of the risk factors including dietary habit, source of water supply, presence of toilet facility, type of house and cohabitation with pigs although higher odds ratio was observed for family size of more than 5 members, age > 60 years and those consuming pork. This may have been due to smaller sample which was a limitation in our study. It might also be because neurocysticercosis is transmitted by feco-oral route and infective stage may have been harboring in the community.
On the basis of clinical and imaging findings, the serological test was found to have sensitivity of 41.5% and specificity of 98.4% with the positive predictive value of 92.3% and negative predictive value of 81.8%. So, in the settings where imaging facilities are not available a positive serological test could qualify to start the treatment for NCC. In conditions of negative serological test but if NCC is suspected on clinical grounds then neuroimaging is advocated and could be the reason for referral for neuroimaging. Caution has to be taken while starting antiparasitic therapy without neuroimaging as there may be extraparenchymal lesion(s) though the percentage for so is low. These can be associated with intense inflammatory reactions and complications.
Thus the antigen ELISA test may have stronger implication in clinical decision making in cases of clinically compatible NCC with neuroimaging unavailable or inconclusive. Further large scale studies are required to establish the true seroprevalence and verifying the strength of the test.
